{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:25:05Z","timestamp":1791354305696,"version":"4.3.1"},"reference-count":114,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["RO1 CA156661"],"award-info":[{"award-number":["RO1 CA156661"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Carbohydrates are regarded as promising targets for vaccine development against infectious disease because cell surface glycans on many infectious agents are attributed to playing an important role in pathogenesis. In addition, oncogenic transformation of normal cells, in many cases, is associated with aberrant glycosylation of the cell surface glycan generating tumor associated carbohydrate antigens (TACAs). Technological advances in glycobiology have added a new dimension to immunotherapy when considering carbohydrates as key targets in developing safe and effective vaccines to combat cancer, bacterial infections, viral infections, etc. Many consider effective vaccines induce T-cell dependent immunity with satisfactory levels of immunological memory that preclude recurrence. Unfortunately, carbohydrates alone are poorly immunogenic as they do not bind strongly to the MHCII complex and thus fail to elicit T-cell immunity. To increase immunogenicity, carbohydrates have been conjugated to carrier proteins, which sometimes can impede carbohydrate specific immunity as peptide-based immune responses can negate antibodies directed at the targeted carbohydrate antigens. To overcome many challenges in using carbohydrate-based vaccine design and development approaches targeting cancer and other diseases, zwitterionic polysaccharides (ZPSs), isolated from the capsule of commensal anaerobic bacteria, will be discussed as promising carriers of carbohydrate antigens to achieve desired immunological responses.<\/jats:p>","DOI":"10.3390\/vaccines4020019","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T19:24:37Z","timestamp":1463858677000},"page":"19","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses"],"prefix":"10.3390","volume":"4","author":[{"given":"Sharmeen","family":"Nishat","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Green Chemistry and Engineering, University of Toledo, Toledo, OH 43606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andreana","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Green Chemistry and Engineering, University of Toledo, Toledo, OH 43606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00000441-189305000-00001","article-title":"The treatment of malignant tumors by repeated inoculations of erysipelas: With a report of ten original cases","volume":"105","author":"Coley","year":"1893","journal-title":"Am. J. Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri1956","article-title":"The love-hate relationship between bacterial polysaccharides and the host immune system","volume":"6","author":"Mazmanian","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1002\/anie.200501594","article-title":"A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response","volume":"44","author":"Dziadek","year":"2005","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining \u03b2-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"Xin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrd3012","article-title":"Carbohydrate vaccines: Developing sweet solutions to sticky situations?","volume":"9","author":"Astronomo","year":"2010","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1083\/jcb.200711151","article-title":"Regulation of protein O-glycosylation by the endoplasmic reticulum\u2013localized molecular chaperone Cosmc","volume":"182","author":"Ju","year":"2008","journal-title":"J. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1158\/0008-5472.CAN-07-2345","article-title":"Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc","volume":"68","author":"Ju","year":"2008","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cbic.200700310","article-title":"Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells","volume":"9","author":"Adams","year":"2008","journal-title":"ChemBioChem"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1073\/pnas.0800974105","article-title":"Microbial carbohydrate depolymerization by antigen-presenting cells: Deamination prior to presentation by the MHCII pathway","volume":"105","author":"Duan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0264-410X(91)90010-4","article-title":"Induction of antibody and protective responses in mice by Brucella O-polysaccharide-BSA conjugate","volume":"9","author":"Jacques","year":"1991","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3816\/CBC.2003.s.003","article-title":"Clinical development of the STn-KLH vaccine (Theratope)","volume":"3","author":"Ibrahim","year":"2003","journal-title":"Clin. Breast Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bmb\/ldh021","article-title":"Bacterial polysaccharide\u2013protein conjugate vaccines","volume":"70","author":"Finn","year":"2004","journal-title":"Br. Med. Bull."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJM199011153232004","article-title":"A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type B disease","volume":"323","author":"Eskola","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(94)90103-1","article-title":"Immunogenicity in cows of Staphylococcus aureus type 5 capsular polysaccharide\u2014Ovalbumin conjugate","volume":"12","author":"Gilbert","year":"1994","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1073\/pnas.96.9.5194","article-title":"Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1","volume":"96","author":"Pozsgay","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.vaccine.2003.11.034","article-title":"Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: From the lab bench to phase III clinical trials","volume":"22","author":"Fattom","year":"2004","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/cbic.200700225","article-title":"Anti-carbohydrate antibodies elicited by polyvalent display on a viral scaffold","volume":"8","author":"Kaltgrad","year":"2007","journal-title":"ChemBioChem"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/285664a0","article-title":"Carrier-priming leads to hapten-specific suppression","volume":"285","author":"Herzenberg","year":"1980","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri3328","article-title":"Recognition of CD1d-restricted antigens by natural killer T cells","volume":"12","author":"Rossjohn","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1126\/science.8211161","article-title":"Structural features of polysaccharides that induce intra-abdominal abscesses","volume":"262","author":"Tzianabos","year":"1993","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.160.10.5000","article-title":"Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis","volume":"160","author":"Gibson","year":"1998","journal-title":"J. Immunol."},{"key":"ref_22","first-page":"7","article-title":"Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC","volume":"3","author":"Natsume","year":"2009","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","article-title":"Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis","volume":"118","author":"Paglino","year":"2004","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.4049\/jimmunol.140.12.4091","article-title":"Thymus-dependent and thymus-independent developmental pathways for peripheral T cell receptor-gamma delta-bearing lymphocytes","volume":"140","author":"Pardoll","year":"1988","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-12-119","article-title":"Extracellular polysaccharides produced by Ganoderma formosanum stimulate macrophage activation via multiple pattern-recognition receptors","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Complement. Altern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1084\/jem.54.3.437","article-title":"Chemo-immunological studies on conjugated carbohydrate-proteins: V. The immunological specifity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with foreign protein","volume":"54","author":"Avery","year":"1931","journal-title":"J. Exp. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/iai.37.1.15-22.1982","article-title":"Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates","volume":"37","author":"Beuvery","year":"1982","journal-title":"Infect. Immun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type B polysaccharide-protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1128\/iai.61.11.4760-4766.1993","article-title":"Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine","volume":"61","author":"Wessels","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.38.1.73","article-title":"The soluble specific substance of pneumococcus","volume":"38","author":"Heidelberger","year":"1923","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0264-410X(94)90194-5","article-title":"Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines","volume":"12","author":"Keitel","year":"1994","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"2","author":"Klugman","year":"1987","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0022-3476(96)70389-X","article-title":"Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children","volume":"128","author":"King","year":"1996","journal-title":"J. Pediatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(00)44360-6","article-title":"A new antigen of B. typhosus: Its relation to virulence and to active and passive immunisation","volume":"224","author":"Felix","year":"1934","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.4049\/jimmunol.0903512","article-title":"Hemoglobin transforms anti-inflammatory Salmonella typhi virulence polysaccharide into a TLR-2 agonist","volume":"184","author":"Garg","year":"2010","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood-2009-11-251884","article-title":"Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells","volume":"116","author":"Schreibelt","year":"2010","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.4049\/jimmunol.1103166","article-title":"The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen","volume":"189","author":"Marshall","year":"2012","journal-title":"J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/1753425915599242","article-title":"MyD88-dependent pro-inflammatory activity in Vi polysaccharide vaccine against typhoid promotes Ab switching to IgG","volume":"21","author":"Garg","year":"2015","journal-title":"Innate Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.vaccine.2007.08.027","article-title":"Typhoid fever vaccines: Systematic review and meta-analysis of randomised controlled trials","volume":"25","author":"Fraser","year":"2007","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM(197) as a new conjugate vaccine against Salmonella Typhi","volume":"29","author":"Micoli","year":"2011","journal-title":"Vaccine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1016\/j.vaccine.2014.10.037","article-title":"Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses","volume":"32","author":"Romeu","year":"2014","journal-title":"Vaccine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","volume":"369","author":"Stephens","year":"2007","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1189\/jlb.0610369","article-title":"Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2","volume":"89","author":"Zughaier","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","article-title":"Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J. Exp. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/iai.34.3.725-732.1981","article-title":"Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults","volume":"34","author":"Griffiss","year":"1981","journal-title":"Infect. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1155\/2014\/237560","article-title":"Safety and immunogenicity of two doses of quadrivalent meningococcal conjugate vaccine or one dose of meningococcal group C conjugate vaccine, both administered concomitantly with routine immunization to 12- to 18-month-old children","volume":"25","author":"Noya","year":"2014","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/INF.0b013e318268dfe4","article-title":"Safety and immunogenicity of a quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants and toddlers: Three multicenter phase III studies","volume":"31","author":"Pina","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14462","DOI":"10.1021\/ja405932r","article-title":"A vision for vaccines built from fully synthetic tumor-associated antigens: From the laboratory to the clinic","volume":"135","author":"Wilson","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1021\/bc200606s","article-title":"Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines","volume":"23","author":"Sundgren","year":"2012","journal-title":"Bioconjugate Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/cb400060x","article-title":"Boosting immunity to small tumor-associated carbohydrates with bacteriophage Q\u03b2 capsids","volume":"8","author":"Yin","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1073\/pnas.1115166109","article-title":"Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine","volume":"109","author":"Lakshminarayanan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.chom.2014.03.006","article-title":"Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms","volume":"15","author":"Dasgupta","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4049\/jimmunol.145.5.1343","article-title":"The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression","volume":"145","author":"Leclerc","year":"1990","journal-title":"J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3816\/CBC.2003.s.002","article-title":"Rationale for the clinical development of STn-KLH (Theratope) and anti-MUC-1 vaccines in breast cancer","volume":"3","author":"Miles","year":"2003","journal-title":"Clin. Breast Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00262-004-0598-5","article-title":"Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: Clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer","volume":"54","author":"Slovin","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0264-410X(94)80052-2","article-title":"Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma","volume":"12","author":"Livingston","year":"1994","journal-title":"Vaccine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.4049\/jimmunol.169.11.6149","article-title":"Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions","volume":"169","author":"Tzianabos","year":"2002","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.vaccine.2010.09.018","article-title":"Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate","volume":"29","author":"Kabanova","year":"2010","journal-title":"Vaccine"},{"key":"ref_62","first-page":"937","article-title":"Bacterial capsular antigens. Structural patterns of capsular antigens","volume":"71","author":"Ovodov","year":"2006","journal-title":"Biochemistry"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/iai.59.6.2075-2082.1991","article-title":"Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis","volume":"59","author":"Pantosti","year":"1991","journal-title":"Infect. Immun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"13478","DOI":"10.1073\/pnas.97.25.13478","article-title":"Structural basis of the abscess-modulating polysaccharide A2 from Bacteroides fragilis","volume":"97","author":"Wang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4049\/jimmunol.172.3.1483","article-title":"Zwitterionic polysaccharides stimulate T cells with no preferential V\u03b2 usage and promote anergy, resulting in protection against experimental abscess formation","volume":"172","author":"Stingele","year":"2004","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1073\/pnas.161175598","article-title":"Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides","volume":"98","author":"Tzianabos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.4049\/jimmunol.179.12.8208","article-title":"Introduction of zwitterionic motifs into bacterial polysaccharides generates TLR2 agonists able to activate APCs","volume":"179","author":"Gallorini","year":"2007","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1084\/jem.20062008","article-title":"A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2","volume":"203","author":"Wang","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/0003-4819-86-5-569","article-title":"Bacteroides fragilis Subspecies in Clinical Isolates","volume":"86","author":"Polk","year":"1977","journal-title":"Ann. Intern. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/infdis\/136.1.82","article-title":"The capsular polysaccharide of Bacteroides fragilis as a virulence factor: Comparison of the pathogenic potential of encapsulated and unencapsulated strains","volume":"136","author":"Onderdonk","year":"1977","journal-title":"J. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/infdis\/140.5.724","article-title":"Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis","volume":"140","author":"Kasper","year":"1979","journal-title":"J. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1172\/JCI118340","article-title":"Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis","volume":"96","author":"Tzianabos","year":"1995","journal-title":"J. Clin. Invest."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1084\/jem.155.4.1188","article-title":"Cellular immunity to Bacteroides fragilis capsular polysaccharide","volume":"155","author":"Shapiro","year":"1982","journal-title":"J. Exp. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1021\/bi00131a026","article-title":"Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy","volume":"31","author":"Baumann","year":"1992","journal-title":"Biochemistry"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2004.05.001","article-title":"Polysaccharide processing and presentation by the MHCII pathway","volume":"117","author":"Cobb","year":"2004","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1462-5822.2005.00591.x","article-title":"Zwitterionic capsular polysaccharides: The new MHCII-dependent antigens","volume":"7","author":"Cobb","year":"2005","journal-title":"Cell. Microbiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4049\/jimmunol.164.2.719","article-title":"Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity","volume":"164","author":"Tzianabos","year":"2000","journal-title":"J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2005.05.007","article-title":"An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system","volume":"122","author":"Mazmanian","year":"2005","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2741\/3603","article-title":"Beneficial effects of Bacteroides fragilis polysaccharides on the immune system","volume":"15","author":"Troy","year":"2010","journal-title":"Front. Biosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"16753","DOI":"10.1073\/pnas.0505688102","article-title":"Modulation of surgical fibrosis by microbial zwitterionic polysaccharides","volume":"102","author":"Chung","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.4049\/jimmunol.163.3.1420","article-title":"IL-10 transgenic mice present a defect in T cell development reminiscent of SCID patients","volume":"163","author":"Rouleau","year":"1999","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-065X.2011.01075.x","article-title":"The yin yang of bacterial polysaccharides: Lessons learned from B. fragilis PSA","volume":"245","author":"Surana","year":"2012","journal-title":"Immunol. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0008-6215(00)83664-2","article-title":"Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 1","volume":"78","author":"Lindberg","year":"1980","journal-title":"Carbohydr. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2567.2008.02924.x","article-title":"Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation","volume":"127","author":"Velez","year":"2009","journal-title":"Immunology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/jcm.25.3.526-530.1987","article-title":"Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8","volume":"25","author":"Hochkeppel","year":"1987","journal-title":"J. Clin. Microbiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0732-8893(84)90002-6","article-title":"Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus","volume":"2","author":"Arbeit","year":"1984","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.carres.2005.02.001","article-title":"Revised structures for the capsular polysaccharides from Staphylococcus aureus Types 5 and 8, components of novel glycoconjugate vaccines","volume":"340","author":"Jones","year":"2005","journal-title":"Carbohydr. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9622","DOI":"10.1021\/ja902607a","article-title":"Immunological response from an entirely carbohydrate antigen: Design of synthetic vaccines based on Tn\u2212PS A1 conjugates","volume":"131","author":"Wang","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/anie.201002313","article-title":"The Tn antigen-structural simplicity and biological complexity","volume":"50","author":"Ju","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1039\/C4OB00128A","article-title":"Synthesis of the tumor associative alpha-aminooxy disaccharide of the TF antigen and its conjugation to a polysaccharide immune stimulant","volume":"12","author":"Bourgault","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1039\/C4MD00038B","article-title":"Elucidating structural features of an entirely carbohydrate cancer vaccine construct employing circular dichroism and fluorescent labeling","volume":"5","author":"Trabbic","year":"2014","journal-title":"MedChemComm"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00262-012-1205-9","article-title":"The entirely carbohydrate immunogen Tn-PS A1 induces a cancer cell selective immune response and cytokine IL-17","volume":"61","author":"Appulage","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nature07008","article-title":"A microbial symbiosis factor prevents intestinal inflammatory disease","volume":"453","author":"Mazmanian","year":"2008","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1348-0421.2007.tb04008.x","article-title":"Interleukin-17 as an effector molecule of innate and acquired immunity against infections","volume":"51","author":"Matsuzaki","year":"2007","journal-title":"Microbiol. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood.V99.6.2114","article-title":"Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism","volume":"99","author":"Benchetrit","year":"2002","journal-title":"Blood"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.icb.7100062","article-title":"The advent of the cytokine storm","volume":"85","author":"Clark","year":"2007","journal-title":"Immunol. Cell. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.1206095","article-title":"The Toll-like receptor pathway establishes commensal gut colonization","volume":"332","author":"Round","year":"2011","journal-title":"Science"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/glycob\/cwl056","article-title":"Structure and function relations with a T-cell-activating polysaccharide antigen using circular dichroism","volume":"17","author":"Kreisman","year":"2007","journal-title":"Glycobiology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1021\/acs.orglett.5b00512","article-title":"Stereoselective synthesis of natural and non-natural thomsen-nouveau antigens and hydrazide derivatives","volume":"17","author":"Shaik","year":"2015","journal-title":"Org. Lett."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/07328303.2014.925913","article-title":"Synthesis of an aminooxy derivative of the trisaccharide globotriose Gb3","volume":"33","author":"Ghosh","year":"2014","journal-title":"J. Carbohydr. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Ghosh, S., Nishat, S., and Andreana, P.R. (2016). Synthesis of an aminooxy derivative of the tetrasaccharide repeating unit of streptococcus dysgalactiae 2023 polysaccharide for a PS A1 conjugate vaccine. J. Org. Chem.","DOI":"10.1021\/acs.joc.6b00195"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1002\/chem.200400074","article-title":"The Immunogenicity of the tumor-associated antigen lewisy may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein","volume":"10","author":"Buskas","year":"2004","journal-title":"Chem. Eur. J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1016\/j.vaccine.2011.09.009","article-title":"Cancer vaccines and carbohydrate epitopes","volume":"29","author":"Lum","year":"2011","journal-title":"Vaccine"},{"key":"ref_106","unstructured":"Trabbic, K.R., Bourgault, J.P., Shi, M., and Andreana, P.R. (2016). Unpublished data."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1039\/C6OB00176A","article-title":"Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich\u2014PS B conjugate","volume":"14","author":"Trabbic","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/fon.13.209","article-title":"Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer","volume":"10","author":"Ferguson","year":"2014","journal-title":"Future Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1128\/IAI.01492-08","article-title":"Oligoclonal CD4+ T cells promote host memory immune responses to zwitterionic polysaccharide of streptococcus pneumoniae","volume":"77","author":"Groneck","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/infdis\/148.6.1136","article-title":"Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups","volume":"148","author":"Robbins","year":"1983","journal-title":"J. Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4049\/jimmunol.181.2.1323","article-title":"IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection","volume":"181","author":"McLoughlin","year":"2008","journal-title":"J. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2012.00016","article-title":"Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials","volume":"2","author":"Bagnoli","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1002\/chem.200902460","article-title":"Synthesis of monomeric and dimeric repeating units of the zwitterionic type 1 capsular polysaccharide from Streptococcus pneumoniae","volume":"16","author":"Wu","year":"2010","journal-title":"Chem. Eur. J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1021\/ja1087375","article-title":"Total synthesis of the Bacteroides fragilis zwitterionic polysaccharide A1 repeating unit","volume":"133","author":"Pragani","year":"2011","journal-title":"J. Am. Chem. Soc."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/4\/2\/19\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:24:16Z","timestamp":1760210656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/4\/2\/19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":114,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6]]}},"alternative-id":["vaccines4020019"],"URL":"https:\/\/doi.org\/10.3390\/vaccines4020019","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,20]]}}}